11 – 20 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Dread and Risk Elimination Premium for the Value of a Statistical Life
2016) In Working Papers(
- Working paper/Preprint › Working paper
-
Mark
Measuring the End of Life Premium in Cancer using Individual ex ante Willingness to Pay
2016) In Working Papers(
- Working paper/Preprint › Working paper
-
Mark
Value of a QALY and VSI Estimated with the Chained Approach
(
- Working paper/Preprint › Working paper
-
Mark
Chained Approach vs Contingent Valuation for Estimating the Value of Risk Reduction
(
- Working paper/Preprint › Working paper
-
Mark
Betalningsviljan för att minska risken för icke-dödliga och dödliga skador i samband med vägtrafikolyckor – en pilotstudie med jämförelse av CV och kedje-ansats
2016) In IHE Rapport(
- Book/Report › Report
-
Mark
Betalningsviljan för att minska risken för icke-dödliga och dödliga skador i samband med vägtrafikolyckor – en studie med kedje-ansats
2016) In IHE Rapport(
- Book/Report › Report
-
Mark
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden
(
- Contribution to journal › Article
-
Mark
Value of treatment in clinical trials versus the real world : the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden
(
- Contribution to journal › Article
-
Mark
Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
(
- Contribution to journal › Article
-
Mark
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe
(
- Contribution to journal › Article